The role of caveolin-1 in cardiovascular regulation
Article first published online: 25 SEP 2008
DOI: 10.1111/j.1748-1716.2008.01907.x
© 2008 The Authors. Journal compilation © 2008 Scandinavian Physiological Society
Additional Information
How to Cite
Rahman, A. and Swärd, K. (2009), The role of caveolin-1 in cardiovascular regulation. Acta Physiologica, 195: 231–245. doi: 10.1111/j.1748-1716.2008.01907.x
Publication History
- Issue published online: 5 JAN 2009
- Article first published online: 25 SEP 2008
- Received 16 June 2008, revision requested 27 August 2008, revision received 1 September 2008, accepted 23 September 2008
- Abstract
- Article
- References
- Cited By
Keywords:
- blood pressure;
- cavolin-1;
- eNOS;
- free radicals;
- lipid rafts;
- pulmonary hypertension
Abstract
Caveolae are omega-shaped membrane invaginations present in essentially all cell types in the cardiovascular system, and numerous functions have been ascribed to these structures. Caveolae formation depends on caveolins, cholesterol and polymerase I and transcript release factor-Cavin (PTRF-Cavin). The current review summarizes and critically discusses the cardiovascular phenotypes reported in caveolin-1-deficient mice. Major changes in the structure and function of heart, lung and blood vessels have been documented, suggesting that caveolae play a critical role at the interface between blood and surrounding tissue. According to an emerging paradigm, many of these changes are secondary to uncoupling of endothelial nitric oxide synthase. Thus, nitric oxide synthase not only synthesizes more nitric oxide in the absence of caveolin-1, but also more superoxide with potential pathogenic consequences. It is further argued that the vasodilating drive from increased nitric oxide production in caveolin-1-deficient mice is balanced by changes in the vascular media that favour increased dynamic resistance regulation. Harnessing the therapeutic opportunities buried in caveolae, while challenging, could expand the arsenal of treatment options in cancer, lung disease and atherosclerosis.

1748-1716/asset/olbannercenter.gif?v=1&s=d77126e9bca501df7554d8c1578bcba3ce3110cc)
